autoimmune hemolytic anemia
Information
- Disease name
- autoimmune hemolytic anemia
- Disease ID
- DOID:718
- Description
- "A hemolytic anemia that is characterized by deficient red blood cells caused by auto-antibodies." [url:http\://en.wikipedia.org/wiki/Autoimmune_hemolytic_anemia] {comment="sn:IEDB"}
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04657094 | Active, not recruiting | Phase 2 | Acalabrutinib for the Treatment of Relapsed or Refractory Autoimmune Hemolytic Anemia in Patients With Chronic Lymphocytic Leukemia | March 16, 2021 | December 30, 2024 |
| NCT03576742 | Active, not recruiting | Severe Immune Cytopenia Registry Www.Sic-reg.Org | March 9, 2018 | December 31, 2024 | |
| NCT02389231 | Completed | Phase 1/Phase 2 | Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment | May 17, 2017 | November 16, 2018 |
| NCT02689986 | Completed | Phase 2 | Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease | January 2013 | December 2016 |
| NCT03269292 | Completed | Clinical Characteristics and Treatment Outcomes of Patients With Autoimmune Hemolytic Anemia | October 1, 2017 | January 24, 2021 | |
| NCT03538041 | Completed | Phase 2 | A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia | November 21, 2018 | April 2, 2024 |
| NCT00001630 | Completed | Phase 1 | Treatment of Autoimmune Thrombocytopenia (AITP) | July 21, 1997 | June 11, 2009 |
| NCT02158195 | Completed | Immunopathology of Autoimmune Hemolytic Anemia | July 3, 2013 | December 27, 2018 | |
| NCT04057703 | Completed | Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia. | January 18, 2016 | December 4, 2016 | |
| NCT04083014 | Completed | Phase 2 | Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic Anemia | August 20, 2019 | March 20, 2024 |
| NCT05711264 | Not yet recruiting | Presence of Circulating Cluster of Differentiation 4 Positive 28 Null T Helper Lymphocytes(CD4+CD28-) in Patients With Autoimmune Hemolytic Anemia. | January 30, 2023 | April 1, 2025 | |
| NCT04814394 | Not yet recruiting | The Significance of Release of T-follicular Helper and T-follicular Regulatory Cells in Autoimmune Haemolytic Anemia Before and After Tratment | April 1, 2022 | December 1, 2026 | |
| NCT06212154 | Recruiting | Phase 1 | CAR-T for Autoimmune Hemolytic Anemia Patients Who Have Failed Three or More Lines of Therapy | January 20, 2024 | June 30, 2025 |
| NCT06231368 | Recruiting | Phase 1 | CNCT19 for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy. | February 4, 2024 | August 31, 2025 |
| NCT04005638 | Recruiting | Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia | February 2, 2019 | January 2025 | |
| NCT04024202 | Recruiting | Data Registry of Auto Immune Hemolytic Anemia | July 12, 2019 | December 1, 2024 | |
| NCT05263817 | Recruiting | Early Phase 1 | A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and Vasculitis | October 8, 2021 | October 1, 2024 |
| NCT05694312 | Recruiting | Phase 2 | Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL | November 24, 2023 | November 2026 |
| NCT05931718 | Recruiting | Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia | June 1, 2021 | June 2030 | |
| NCT05937828 | Recruiting | OBS'CEREVANCE: French Cohort of Pediatric Autoimmune Cytopenia | September 1, 2010 | December 31, 2029 | |
| NCT02877706 | Recruiting | French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia | June 2013 | June 2029 | |
| NCT05089227 | Recruiting | Phase 2 | Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study | February 3, 2022 | August 2025 |
| NCT05676697 | Terminated | Phase 1 | PI3K Delta Inhibitor in Relapsed / Refractory Autoimmune Hemolytic Anemia Patients After Receiving Two or More Lines of Therapy | January 13, 2023 | February 6, 2024 |
| NCT02828670 | Unknown status | Role of T Follicular Helper Cells in Autoimmune Hemolytic Anemia (TFH in AIHA) | June 7, 2016 | June 2023 | |
| NCT05057481 | Unknown status | Phase 3 | Reappraisal of the Therapies of Refractory Autoimmune Hemolytic Anemia in Systemic Lupus Erythematosus | September 15, 2021 | January 15, 2023 |
| NCT03918265 | Unknown status | Phase 4 | Tacrolimus Treatment for Refractory Autoimmune Cytopenia | May 4, 2019 | November 10, 2021 |
| NCT04039477 | Withdrawn | Phase 2 | A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP | July 2020 | August 5, 2020 |
- Disase is a (Disease Ontology)
- DOID:583
- Cross Reference ID (Disease Ontology)
- GARD:5870
- Cross Reference ID (Disease Ontology)
- ICD9CM:283.0
- Cross Reference ID (Disease Ontology)
- MESH:D000744
- Cross Reference ID (Disease Ontology)
- MIM:205700
- Cross Reference ID (Disease Ontology)
- NCI:C34378
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:25121006
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0002880
- Exact Synonym (Disease Ontology)
- Autoimmune haemolytic anaemia
- Exact Synonym (Disease Ontology)
- autoimmune hemolytic anaemia
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0001890
- OrphaNumber from OrphaNet (Orphanet)
- 98375